Bristol Myers Squibb invests $2.3 billion in new Houston manufacturing campus

Bristol Myers Squibb to build a modular, multi-modal manufacturing campus in Houston, Texas, investing about $2.3 billion.

• The site at Generation Park spans about 600,000 square feet, targeting drug product and finished-goods output from late development through launch.
• The campus is designed to add or reconfigure capacity, supporting multiple modalities including small molecules, biologics and antibody-drug conjugates.
• The plan includes nearly 500 skilled jobs at the start, with about 2,000 construction and indirect jobs expected during the 2027-2030 buildout.
• The project ties to a $40 billion, five-year U.S. investment commitment across R&D, technology and domestic manufacturing.